Drug
Via 3196
Via 3196: highest development phase Phase 1, developed by Madrigal Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Madrigal Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| VIA-3196 NCT01367873 | Phase 1 | Drug Safety |
| VIA-3196 NCT01519531 | Phase 1 | Drug Safety |
Latest
No recent events.
Follow Via 3196 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.